ЗА ТОЗИ ПОДКАСТ 🔗
Peptides Explained breaks down the most talked-about peptides and GLP-1 medications in health, fitness, and longevity — including semaglutide, tirzepatide, BPC-157, TB-500, and more.
Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language.
No bro science. No hype. Just clear, foundational education.
For informational purposes only. Not medical advice.
For Research Peptides; Offlinepeptides.com/ref/johngarrett/
https://www.skool.com/peptides-explained-15
Hosted by Registered Nurse John Garrett, this podcast explains how these compounds work, why they're popular, what the research shows, and the real risks and side effects — all in plain language.
No bro science. No hype. Just clear, foundational education.
For informational purposes only. Not medical advice.
For Research Peptides; Offlinepeptides.com/ref/johngarrett/
https://www.skool.com/peptides-explained-15
Водещи:
Честота на актуализиране:
semiweekly
Средна дължина на звука:
19 minutes
Английски
САЩ
62 епизода
от 22 Февруари 2026
episodic
AUDIENCE OF THIS PODCAST 🔗
~97.86% of listeners are from Canada.
🇨🇦
CA
97.86%
🇺🇸
US
1.90%
🇨🇼
CW
0.23%
Others
0.01%
* Data source: directly measured on Listen Notes. в реално време
ПОСЛЕДЕН ЕПИЗОД 🔗
Eli Lilly is taking legal action against businesses selling products labeled retatrutide. What do the lawsuits actually establish—and what don't they? John Garrett separates pending legal allegations from court findings, reviews the human trial evidence for the investigational triple agonist, and e…
ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ
Търсене в минали епизоди на Peptides Explained.
ПРЕДИШНИ ЕПИЗОДИ 🔗
Can peptide biology protect the brain from vascular damage? John follows a question that started with Vesugen into the biology of vascular cognitive impairment—endothelial dysfunction, hypoperfusion, blood-brain-barrier injury, mitochondrial stress, inflammation and neuronal damage. The episode map…
Everyone keeps calling belly fat "visceral fat." That is not how anatomy works. In this crossover episode, John breaks down the difference between visceral and subcutaneous fat, why visceral adipose tissue matters metabolically, how it is actually measured, what waist circumference can and cannot t…
Vesugen is only three amino acids long: lysine, glutamate, and aspartate — KED. Yet it is promoted as a vascular bioregulator that may support endothelial health and even "rejuvenate" aging blood vessels.
In this episode, John Garrett looks at what the endothelial research actually measured, the p…
FLGR-242 is being called a smarter, longer-acting follistatin. John examines the advertised construct, the activin-sparing and 19-day half-life claims, the difference between pathway evidence and product evidence, and why transformation photos cannot establish pharmacology or safety.
Follistatin can bind myostatin—one of the body's major restraints on skeletal-muscle growth. Animal studies are dramatic, and small human gene-therapy studies have produced encouraging signals in serious muscle disease.
But is a vial labeled "Follistatin-344" equivalent to the therapy used in thos…
Glutathione gets called the "master antioxidant," and the underlying biology really is important. But does that mean oral supplements, liposomal products or glutathione IVs deliver the sweeping detox, energy, immune and anti-aging benefits often attached to them?
John breaks down glutathione biolo…
For more information on Research Peptides go to PeptidesExplained.info/OfflinePeptides
Is taking smaller GLP-1 doses multiple times per week actually "microdosing"? Not necessarily.
This episode separates split dosing from true dose reduction and explains the pharmacokinetic logic using semagluti…
Download The Peptide App at ThePeptide.App/Explained
For more information on research peptides check out PeptidesExplained.info/OfflinePeptides
A peptide…in a pill?
Icotyde, or icotrokinra, is an FDA-approved oral peptide designed to block the IL-23 receptor in moderate-to-severe plaque psoriasi…
If BPC-157, TB-500, KPV, MOTS-C and similar peptides are so interesting, why don't we have giant randomized human trials?
This episode looks at the less dramatic—and more important—answer: clinical trials require a sponsor, regulatory strategy, manufacturing package, defined indication, safety pro…
Опровержение: Подкастът и произведенията на изкуството, вградени на тази страница, са от John Garrett, което е собственост на неговия собственик и не е свързано с или одобрено от Listen Notes, Inc.
ПОДКАСТ ТЪРСАЧКА
Можете да използвате нашия уебсайт, за да търсите3,826,039подкасти и195,985,082епизоди по хора, места или теми.
I have no special talent. I am only passionately curious, and
I listen to podcasts.
‐ Albert "Llamacorn" Einstein
ТЪРСЕНЕ на МИНАЛИ ЕПИЗОДИ
Търсене в минали епизоди на Peptides Explained.
ПОИСКАЙТЕ ПРАВАТА ЗА ТОЗИ ПОДКАСТ
Why to claim podcasts?
If you are a podcaster, the best way to manage your podcasts on Listen Notes is by claiming your Listen Notes
podcast pages.
It is a great, free way to engage the podcast community and increase the visibility of your podcasts.
After claiming your Listen Notes podcast pages, you will be able to:
✓
Manually refresh the RSS feed to sync up
✓
Get a verified badge (
✓
) alongside with your podcast name on Listen Notes
✓
Post обяви for sponsorship,
guests, co-hosts,
cross-promotion...
✓
Respond to listener comments on Listen Notes
✓
Use speech-to-text techniques to transcribe your show and
edit transcripts
✓
Improve the presence of your podcasts, e.g., self-service
интервю с подкастър...
✓
If you share your Listen Notes page and at-mention @ListenNotes
on X (formerly Twitter),
нашият официален акаунт в X (бивш Twitter) will retweet to promote
your show to our followers.
Coming soon:
◯ Self-service promotion on Listen Notes
◯ Track your podcast stats on Listen
Notes, e.g., listens, page
views...
◯ Manage episodes
РЕДАКТИРАНЕ
Благодарим Ви, че помогате да поддържаме базата данни за подкастове актуална.
